Extending the Time for Thrombolysis in Emergency Neurological Deficits "EXTEND"

Recruiting

Phase 3 Results N/A

References

Related Links

National Stroke Research Institute

Sources for Trial Information

National Stroke Research Institute, Australia
ClinicalTrials.gov

Staticmap?size=198x113&sensor=false&zoom=1&markers=-31.9504, 115.861&markers=-37.8137, 145.119&markers=-34.9207, 138.609&markers=-37.7992, 144.956&markers=-33.8027, 150.989&markers=-35.0217, 138.568&markers=-33.2531, 151.493&markers=-32.9227, 151.693&markers=-33.8213, 151.191&markers=-33.88, 151.221&markers=-27.4479, 153.029&markers=-26.623, 152.955&markers=-37.9204, 145.121&markers=-37.7918, 144.887&markers=-37.7566, 145.058&markers=-37.8172, 144.993&markers=-31.9683, 115.815&markers=-36.853, 174

View Trial Locations

Recruitment

Enrollment: 400
Gender: Both
Minimum Age: 18 Years
Accepts Healthy Volunteers: No
18 locations, 2 countries

Principal Investigator

Geoffrey Donnan, MD FRACP
National Stroke Research Institute, Australia
Stephen Davis, MD FRACP
University of Melbourne

NCT00887328 ClinicalTrials.gov →